Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

West Announces Plan to Consolidate Certain Operations

By Pharmaceutical Processing | December 7, 2010

West Pharmaceutical Services
today announced its intention to consolidate selected operations in order to
improve operating efficiencies. The company expects to close its Montgomery, Pennsylvania,
USA manufacturing facility
and to downsize operations at its facility in St. Austell, Cornwall, U.K.
The Pennsylvania
facility has been engaged primarily in contract manufacturing of molded plastic
components and assemblies for consumer-product applications. The Cornwall facility
produces molded elastomeric components for disposable medical devices, as well
as elastomeric and plastic components used in pharmaceutical packaging.
Ancillary to the manufacturing changes West is also planning to eliminate a
limited number of other operational and administrative roles.

“The changing landscapes in the healthcare and consumer
markets we serve require that we regularly evaluate our operations and adapt to
changing conditions in order to successfully compete,” said Donald E.

Morel Jr., Ph.D., Chairman and Chief Executive Officer.
“The plans announced today will reduce the manufacturing capacity devoted
to product lines that no longer support sustainable, competitive operations,
and will unfortunately result in the loss of a number of jobs over time. These
are difficult decisions that fall most heavily on our employees in these
locations, and we will be providing support that should ease the burden placed
on them.” The costs of the restructuring are expected to be between $18
million and $21 million. When fully implemented, the changes are expected to reduce
annual operating costs by approximately $12 million.

 

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE